Instalab
logoInstalab

Gardnerella Vaginalis

Vaginal Swab Test
The clearest molecular read on whether your vaginal microbiome has tipped toward bacterial vaginosis, beyond what a swab smell test can tell you.
4.8 (4,562 reviews)
Tested by US Biotek Laboratories
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Gardnerella Vaginalis test?

This test is most useful if any of these apply to you.

Dealing With Recurring BV
If bacterial vaginosis keeps coming back despite treatment, this test shows which Gardnerella strains are persisting and whether the underlying ecology has actually shifted.
Planning or Going Through Pregnancy
Higher Gardnerella loads in pregnancy are linked to preterm birth risk and BV complications, so knowing your number gives you a chance to address imbalances early.
Unsure What Your Symptoms Mean
If you have unusual discharge, odor, or itching but standard exams have been inconclusive, this molecular test cuts through the ambiguity with a quantitative read.
Optimizing Your Vaginal Microbiome
If you are tracking your overall microbial health and want to know whether your vaginal community is Lactobacillus-dominated or tipping toward dysbiosis, this gives you a baseline.

About Gardnerella Vaginalis

If you have ever dealt with recurring vaginal odor, unusual discharge, or a stubborn case of bacterial vaginosis that keeps coming back, this is the bacterium at the center of the story. A vaginal swab measuring Gardnerella vaginalis tells you how much of this organism is present in your vaginal microbial community, and that single piece of information can reframe what your symptoms actually mean.

The catch is that Gardnerella is common in many women without any symptoms at all. What separates a normal finding from a meaningful one is the load, the mix of strains, and what other bacteria are alongside it. Reading this result well means understanding when high levels actually signal trouble.

What This Bacterium Actually Is

Gardnerella vaginalis (often shortened to G. vaginalis) is a bacterium, not a hormone or chemical your body makes. It lives on the lining of the vagina, and sometimes the cervix, as part of the broader community of microbes that share that space. The test on a vaginal swab counts how much of its DNA is present, often as part of a panel that also measures Lactobacillus species and other bacteria linked to bacterial vaginosis (BV).

Many Gardnerella strains produce an enzyme called sialidase, which breaks down the protective mucus layer that lines the vagina. Strains carrying this enzyme are the ones most strongly linked to BV and to the sticky bacterial film, called a biofilm, that coats vaginal cells in BV. Strains without sialidase are more often found in women without BV.

Why It Matters for Bacterial Vaginosis

This test is most useful as part of diagnosing or tracking bacterial vaginosis, the most common cause of abnormal vaginal discharge and odor in women of reproductive age. A healthy vaginal community is usually dominated by Lactobacillus species, which keep the environment acidic and inhospitable to other microbes. BV is what happens when that protective layer thins out and a mix of anaerobic bacteria, with Gardnerella often at the center, takes over.

In one study tracking women with repeated vaginal swabs, a sharp rise in Gardnerella abundance preceded a new BV diagnosis, suggesting this organism plays an active role in tipping the community into BV rather than just showing up afterward. Diagnostic panels that count all four major Gardnerella strain groups distinguish BV-type microbiota from normal microbiota with high accuracy, better than measuring the sialidase gene alone.

What this means for you: a single positive result for Gardnerella does not mean you have BV. The whole picture matters, including how much is present, whether multiple strains are detected, and what else is growing alongside it.

Treatment Outcomes and Recurrence

If you have BV and start treatment, what happens to Gardnerella matters for whether the BV stays gone. After five days of intravaginal metronidazole gel, women whose BV resolved showed roughly a thousand to ten thousand fold drop in Gardnerella by one month, while women whose BV persisted showed almost no change. In other research, persistently high Gardnerella after antibiotics was linked to higher odds of BV coming back within a month.

There is also a biofilm wrinkle. In a small biopsy study, even when symptoms cleared after a week of oral metronidazole, an adherent Gardnerella-dominated biofilm sometimes stayed attached to the vaginal lining and resurged later. This helps explain why BV recurrence is so common even after textbook treatment.

Pregnancy and Cervical Health Associations

Higher Gardnerella loads and the presence of multiple strain groups, especially clade 2, have been linked to BV during pregnancy and to broader shifts away from a Lactobacillus-dominated community. In an analysis of women with HPV infection, high-risk HPV infection and cervical lesions were associated with increased Gardnerella and Prevotella in the vaginal microbiota. In another study of women with high-grade cervical lesions (CIN2), those with a Lactobacillus-dominant microbiome were more likely to see their lesions regress on their own.

These are associations, not proof that Gardnerella itself causes HPV persistence or pregnancy complications. But they fit a consistent pattern where a Gardnerella-heavy, low-Lactobacillus environment is a less hospitable backdrop for several aspects of reproductive health.

HIV and Other Infections

In a prospective study of African couples, women with BV had more than a three-fold increased risk of transmitting HIV to a male partner compared with women without BV. A meta-analysis found that women with BV had nearly a two-fold higher risk of acquiring Trichomonas vaginalis infection. Another meta-analysis showed BV is associated with a significantly increased risk of acquiring herpes simplex virus type 2. These outcomes are tied to the broader BV state rather than to Gardnerella alone, but Gardnerella is one of the most consistent markers of that state.

Why One Reading Is Not Enough

The vaginal microbiome shifts constantly. It changes across the menstrual cycle, after sexual activity, with new partners, with hormonal contraception, and during pregnancy. A single Gardnerella count is a snapshot, not a verdict. Studies that track women over weeks show Gardnerella levels can rise and fall meaningfully across short windows, which is part of why incident BV can be predicted by watching the trajectory rather than relying on one reading.

A reasonable approach is to test when you have symptoms or active concern, retest about a month after any treatment to confirm Gardnerella has actually dropped, and if you have a history of recurrence, retest at three to six months even when you feel fine. The goal is to catch a brewing imbalance before it produces symptoms, not to chase a single number.

When Results Can Be Misleading

Several factors can distort a single reading and lead to the wrong conclusion. The most common ones cluster around what you have been doing in the days before the swab and what else is happening in your body.

  • Recent sexual activity: penile-vaginal sex and sex with a new partner have been shown to shift the vaginal community toward Gardnerella-dominated states and increase the diversity of Gardnerella strains detected, sometimes within days.
  • Menstruation: studies of vaginal microbiome have rescheduled visits if women were menstruating because menses can cause transient Gardnerella increases that do not reflect the underlying state.
  • Collection variability: the type of swab, where on the vaginal wall the sample is collected, and how it is stored can introduce technical variation. Following the kit's instructions carefully matters more here than for many other tests.
  • Recent antibiotics or vaginal products: any antibiotic or intravaginal product used in the past few weeks can suppress Gardnerella temporarily without resolving the underlying ecology.

What an Out-of-Pattern Result Should Push You Toward

If your result shows high Gardnerella, the next step is not to start antibiotics on the spot. The first move is to ask whether you have symptoms, what the rest of the panel shows (Lactobacillus, Atopobium or Fannyhessea vaginae, Megasphaera, Prevotella), and whether a Nugent score or Amsel criteria are available. A high Gardnerella with low Lactobacillus and multiple co-occurring BV-associated organisms is a different clinical picture than high Gardnerella with preserved Lactobacillus crispatus.

If you are symptomatic, working with a clinician on a standard course of metronidazole or clindamycin is the established path. If you have recurrent BV, ask about post-treatment retesting to confirm Gardnerella actually dropped, and consider talking with your clinician about adjunct probiotic strategies that have shown effect in trials. If you are pregnant or trying to conceive, BV should be addressed because of the associations with preterm birth and infection acquisition. If you are asymptomatic and Gardnerella is detected at modest levels alongside a Lactobacillus-dominated community, this is often a normal finding in healthy women, and immediate treatment is not supported by evidence.

What Moves This Biomarker

Evidence-backed interventions that affect your Gardnerella Vaginalis level

Decrease
Intravaginal metronidazole gel (0.75%) for 5 days
This is the standard treatment for bacterial vaginosis and it dramatically reduces Gardnerella when it works. In a study of women whose BV was cured, Gardnerella vaginalis dropped roughly 1,000 to 10,000 fold by one month after a 5-day course, while women in whom BV persisted showed almost no change in Gardnerella levels.
MedicationStrong Evidence
Decrease
Oral metronidazole for 7 days
Oral metronidazole reliably lowers Gardnerella in responders and resolves BV symptoms, but the underlying biofilm can persist. In a biopsy study, symptoms cleared but an adherent Gardnerella-dominated biofilm often stayed on the vaginal lining and resurged later, which helps explain BV recurrence. In larger BV cohorts, persistence of Gardnerella after treatment was linked to higher odds of recurrence within one month.
MedicationStrong Evidence
Decrease
Topical clindamycin (intravaginal)
Topical clindamycin reduces Gardnerella colonization in women with BV. In a randomized comparison, both clindamycin and metronidazole lowered Gardnerella, though clindamycin selected for clindamycin-resistant anaerobic rods after therapy, which is a consideration for repeat use.
MedicationStrong Evidence
Decrease
Intravaginal Bacillus spore probiotic spray alongside standard BV therapy
Adding an intravaginal Bacillus spore probiotic to standard BV therapy produced much larger Gardnerella reductions than standard therapy alone. In a randomized pilot trial, the probiotic group showed substantially greater fold reductions in Gardnerella through day 28 compared with controls. Symptom resolution was faster and recurrence lower through day 28.
SupplementStrong Evidence
Increase
Penile-vaginal sex and sex with new partners
Penile-vaginal sex and sex with new partners shift the vaginal community toward Gardnerella-dominated states and increase the diversity of Gardnerella strains detected. This is not just a temporary blip in the lab number; the changes reflect real ecological shifts that increase risk of BV.
LifestyleStrong Evidence
Decrease
Intravaginal Lactobacillus crispatus-based vaginal synbiotic
A multi-strain Lactobacillus crispatus vaginal synbiotic significantly decreased Gardnerella vaginalis abundance compared with placebo in a randomized trial, while promoting a Lactobacillus-dominated community. This points to a way to nudge the underlying ecology back toward a protective state, not just suppress symptoms.
SupplementModerate Evidence
Decrease
Depot medroxyprogesterone acetate (DMPA, injectable contraceptive)
Starting DMPA decreased Gardnerella vaginalis by about 0.21 log10 copies per swab per month, with reductions in total bacterial load and inflammatory cytokines as well. The shift reflects a hormonal change in the vaginal environment rather than a treatment of BV, so the lower Gardnerella reading does not mean you have addressed an underlying problem.
MedicationModerate Evidence
Increase
Smoking cigarettes
In women who have sex with women, smoking was associated with detecting more Gardnerella clades and a higher likelihood of a BV-type vaginal microbiome. Smoking appears to be a real ecological driver of dysbiosis, not just a marker of other risk behavior.
LifestyleModerate Evidence
Decrease
Oral probiotic supplementation for 12 weeks
In a pilot study of women preparing for assisted reproduction, 12 weeks of oral probiotic supplementation produced roughly a 20% decrease in Gardnerella relative abundance in vaginal samples, alongside increases in Lactobacillus and Bifidobacterium. The shift is modest compared with direct vaginal therapy but moves the community in a favorable direction.
SupplementModest Evidence
Increase
Diet high in animal protein (especially red and processed meat) and alcohol
In a study of young women, higher intake of animal protein, especially red and processed meat, and higher alcohol intake were positively associated with Gardnerella levels and a dysbiotic community state. The associations are observational and modest in size, but they fit a pattern where dietary pattern nudges the vaginal community.
DietModest Evidence
Decrease
Higher intake of alpha-linolenic acid (plant omega-3) and fiber
Higher intake of alpha-linolenic acid was associated with more Lactobacillus crispatus and less of a Gardnerella or L. iners-dominated community in observational data on women in reproductive years. The effect is modest and indirect but consistent with a dietary contribution to vaginal microbial health.
DietModest Evidence

Frequently Asked Questions

Panels containing Gardnerella Vaginalis

Gardnerella Vaginalis is included in these pre-built panels.

References

37 studies
  1. Munch MM, Strenk S, Srinivasan S, Fiedler T, Proll S, Fredricks DThe Journal of Infectious Diseases2024
  2. Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, De Ganck C, Temmerman M, Vaneechoutte MBMC Microbiology2004
  3. Hardy L, Jespers V, Van Den Bulck M, Buyze J, Mwambarangwe L, Musengamana V, Vaneechoutte M, Crucitti TPLoS ONE2017
  4. Janulaitiene M, Paliulyte V, Grinceviciene S, Zakareviciene J, Vladisauskiene a, Marcinkute a, Pleckaityte MBMC Infectious Diseases2017